SAN DIEGO, Calif.--After its initial public offering earlier this month, CombiChem announced the achievement of milestones in two of its collaborations. The computational chemistry company here offered 2.25 million shares at $8 per share in the offering managed by BancAmerica Robertson Stephens, Donaldson, Lufkin & Jenrette, and Salomon Smith Barney. CombiChem offered underwriters an option to buy an additional 337,500 shares of common stock to cover over-allotments.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.